VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $9,595,000 | +10.4% | 412,459 | -24.5% | 0.01% | 0.0% |
| Q1 2018 | $8,689,000 | +12.2% | 546,194 | +47.4% | 0.01% | +20.0% |
| Q4 2017 | $7,746,000 | -13.9% | 370,454 | -41.1% | 0.01% | -16.7% |
| Q3 2017 | $8,994,000 | -15.0% | 629,123 | +3.3% | 0.01% | -14.3% |
| Q2 2017 | $10,575,000 | +115.0% | 609,290 | +36.8% | 0.01% | +75.0% |
| Q1 2017 | $4,918,000 | -29.3% | 445,237 | -7.2% | 0.00% | -20.0% |
| Q4 2016 | $6,957,000 | -48.0% | 479,756 | -11.9% | 0.01% | -37.5% |
| Q3 2016 | $13,366,000 | +16.0% | 544,752 | -4.7% | 0.01% | -11.1% |
| Q2 2016 | $11,523,000 | -22.7% | 571,468 | +0.5% | 0.01% | -18.2% |
| Q1 2016 | $14,911,000 | -77.3% | 568,748 | -12.2% | 0.01% | -77.6% |
| Q4 2015 | $65,816,000 | -30.3% | 647,908 | +22.3% | 0.05% | -33.8% |
| Q3 2015 | $94,495,000 | +4.8% | 529,739 | +30.5% | 0.07% | +15.6% |
| Q2 2015 | $90,209,000 | +2928.2% | 406,074 | +2607.2% | 0.06% | +3100.0% |
| Q1 2015 | $2,979,000 | -97.1% | 15,000 | -97.9% | 0.00% | -97.3% |
| Q4 2014 | $104,227,000 | +18.6% | 728,015 | +8.6% | 0.07% | +17.7% |
| Q3 2014 | $87,868,000 | -19.2% | 670,583 | -22.1% | 0.06% | -18.4% |
| Q2 2014 | $108,792,000 | +110.9% | 860,651 | +120.0% | 0.08% | +105.4% |
| Q1 2014 | $51,579,000 | +53.4% | 391,252 | +36.6% | 0.04% | +54.2% |
| Q4 2013 | $33,621,000 | -65.2% | 286,382 | -69.1% | 0.02% | -68.4% |
| Q3 2013 | $96,678,000 | +322.9% | 927,041 | +249.1% | 0.08% | +300.0% |
| Q2 2013 | $22,861,000 | – | 265,582 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |